Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2015, Article ID 594970, 4 pages
http://dx.doi.org/10.1155/2015/594970
Case Report

Extramedullary Hematopoiesis in a Sentinel Lymph Node as an Early Sign of Chronic Myelomonocytic Leukemia

1Physicians Laboratory, 4840 F Street, Omaha, NE 68117, USA
2Department of Pathology, University of Manitoba, MS559S Thorlakson Building, 820 Sherbrook Street, Winnipeg, MB, Canada R3A 1R9
3Department of Pathology and Microbiology, University of Nebraska Medical Center, 985900 Nebraska Medical Center, Omaha, NE 68198, USA
4Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California (USC) and Norris Cancer Center, USC University Hospital, 1441 Eastlake Avenue, Norris Topping Tower 3463, MC 9172, Los Angeles, CA 90033-9172, USA

Received 26 February 2015; Revised 27 March 2015; Accepted 3 April 2015

Academic Editor: Sami Shousha

Copyright © 2015 Joslin M. Bowen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Orazi, J. M. Bennett, U. Germing, R. D. Brunning, B. J. Bain, and J. Thiele, “Chronic myelomonocytic leukemia,” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., pp. 76–79, IARC, Lyon, France, 2008. View at Google Scholar
  2. M. M. Patnaik, S. A. Parikh, C. A. Hanson, and A. Tefferi, “Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review,” British Journal of Haematology, vol. 165, no. 3, pp. 273–286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. Groupe Français de Cytogénétique Hématologique, “Chronic myelomonocytic leukemia: single entity or heterogeneous disorder?: a prospective multicenter study of 100 patients,” Cancer Genetics and Cytogenetics, vol. 55, no. 1, pp. 57–65, 1991. View at Publisher · View at Google Scholar
  4. N. M. Corcoran, A. Tsui, A. J. Costello, and D. Bouchier-Hayes, “Unilateral testicular mass in man with chronic myelomonocytic leukemia: unusual presentation of chronic myelomonocytic leukemia sequela,” Urology, vol. 65, no. 5, p. 1001, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. E. S. Hyams, R. Gupta, J. Melamed, S. S. Taneja, and O. Shah, “Renal involvement by chronic myelomonocytic leukemia requiring nephroureterectomy,” Reviews in Urology, vol. 11, no. 1, pp. 33–37, 2009. View at Google Scholar
  6. R. A. Mathew, J. M. Bennett, J. J. Liu et al., “Cutaneous manifestations in CMML: indication of disease acceleration or transformation to AML and review of the literature,” Leukemia Research, vol. 36, no. 1, pp. 72–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. S. Jaffe, N. L. Harris, H. Stein et al., Eds., World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon, France, 2001.
  8. A. E. Hunter, N. H. Russell, and I. Ellis, “Extramedullary haemopoiesis as a cause of mediastinal lymphadenopathy in chronic myelomonocytic leukaemia,” Clinical and Laboratory Haematology, vol. 12, no. 4, pp. 465–469, 1990. View at Google Scholar · View at Scopus
  9. A. Manoharan, “Malignant pleural effusion in chronic myelomonocytic leukaemia,” Thorax, vol. 46, no. 6, pp. 461–462, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Gong, X. Lu, Y. Fu et al., “Cytological features of chronic myelomonocytic leukaemia in pleural effusion and lymph node fine needle aspiration,” Cytopathology, vol. 21, no. 6, pp. 411–413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Derlin, T. S. Clauditz, and P. Bannas, “18F-FDG PET/CT for staging and detection of extramedullary organ involvement in chronic myelomonocytic leukemia,” Clinical Nuclear Medicine, vol. 39, no. 9, pp. 811–812, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. D. P. O'Malley, Y. S. Kim, S. L. Perkins, L. Baldridge, B. E. Juliar, and A. Orazi, “Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders,” Modern Pathology, vol. 18, no. 12, pp. 1550–1561, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. D. P. O'Malley, “Benign extramedullary myeloid proliferations,” Modern Pathology, vol. 20, no. 4, pp. 405–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Sohawon, K. K. Lau, T. Lau, and D. K. Bowden, “Extra-medullary haematopoiesis: a pictorial review of its typical and atypical locations,” Journal of Medical Imaging and Radiation Oncology, vol. 56, no. 5, pp. 538–544, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. E. K. A. Millar, S. Inder, and J. Lynch, “Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer—a potential diagnostic pitfall,” Histopathology, vol. 54, no. 5, pp. 622–623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Prieto-Granada, N. Setia, and C. N. Otis, “Lymph node extramedullary hematopoiesis in breast cancer patients receiving neoadjuvant therapy: a potential diagnostic pitfall,” International Journal of Surgical Pathology, vol. 21, no. 3, pp. 264–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Takhar, A. Ney, M. Patel, and A. Sharma, “Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer,” BMJ Case Reports, 2013. View at Publisher · View at Google Scholar · View at Scopus